Key Points
- Director Tammy Romo sold 4,922 Tenet Healthcare shares for approximately $1.30 million at an average price of $264.15, reducing her position by 13.78%. She also sold 2,500 additional shares the following day for $652,075.
- Tenet reported strong quarterly results, with earnings of $6.12 per share versus the $4.26 consensus estimate and revenue of $6.04 billion, up 6.8% year over year.
- Wall Street remains broadly positive: 17 analysts rate the stock a Buy and three rate it Hold, producing a “Moderate Buy” consensus and an average price target of $272.25.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director Tammy Romo sold 2,500 shares of the business's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $260.83, for a total value of $652,075.00. Following the completion of the sale, the director directly owned 28,284 shares in the company, valued at $7,377,315.72. This trade represents a 8.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Tammy Romo also recently made the following trade(s):
- On Thursday, August 6th, Tammy Romo sold 4,922 shares of Tenet Healthcare stock. The shares were sold at an average price of $264.15, for a total value of $1,300,146.30.
Tenet Healthcare Stock Performance
Shares of Tenet Healthcare stock opened at $260.33 on Tuesday. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $265.32. The firm's 50-day moving average is $202.01 and its 200 day moving average is $201.90. The stock has a market cap of $20.96 billion, a price-to-earnings ratio of 10.04, a PEG ratio of 1.00 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35.
Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts' consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare's revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have commented on THC shares. Piper Sandler set a $308.00 target price on Tenet Healthcare in a research note on Monday, July 27th. Raymond James Financial set a $270.00 price target on Tenet Healthcare in a report on Monday, July 27th. Weiss Ratings downgraded Tenet Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, June 2nd. Barclays boosted their target price on Tenet Healthcare from $240.00 to $271.00 and gave the stock an "overweight" rating in a research report on Friday, July 24th. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and set a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday, July 28th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $272.25.
Check Out Our Latest Stock Analysis on THC
Institutional Trading of Tenet Healthcare
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at $25,000. Activest Wealth Management purchased a new stake in Tenet Healthcare in the 4th quarter worth $26,000. Elyxium Wealth LLC bought a new stake in Tenet Healthcare during the fourth quarter valued at about $29,000. Canada Pension Plan Investment Board purchased a new position in shares of Tenet Healthcare in the second quarter valued at about $35,000. Finally, Trust Co. of Vermont bought a new position in shares of Tenet Healthcare in the second quarter worth about $37,000. 95.44% of the stock is owned by hedge funds and other institutional investors.
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
